Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2007-07-17
2007-07-17
Campell, Bruce R. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C424S186100, C435S235100
Reexamination Certificate
active
10826929
ABSTRACT:
The invention is for a DNA vaccine expressing the hemagglutinin (HA1) gene of equine-2 influenza virus. By engineering a stop codon within HA1, expression of HA1 is ensured. By encapsulation of the DNA vaccine in liposome and by intranasal inoculation, it is sufficient to elicit protective immunity at a significantly lower dosage compared to a DNA vaccine expressing the full length HA gene. Lower dosage reduces the risk of induction of anti-DNA antibodies. Intranasal inoculation directly to the respiratory epithelial cells reduces the risk of DNA integration. The inventive vaccine is advantageous over current inactivated or live attenuated vaccines, as updating of the vaccine requires only the replacement of the encoding sequence with the new virus.
REFERENCES:
patent: 4619827 (1986-10-01), Bull et al.
patent: 4631191 (1986-12-01), Dale et al.
patent: 4683137 (1987-07-01), Coggins et al.
patent: 4689224 (1987-08-01), Bull et al.
patent: 4693893 (1987-09-01), Campbell
patent: 4920213 (1990-04-01), Dale et al.
patent: 6045790 (2000-04-01), Campbell
patent: 6177082 (2001-01-01), Dowling et al.
patent: 6398774 (2002-06-01), Penner et al.
patent: 6436408 (2002-08-01), Dowling et al.
patent: 6482414 (2002-11-01), Dowling et al.
patent: 2001/0007860 (2001-07-01), Olsen et al.
patent: 2002/0156037 (2002-10-01), Volkin et al.
patent: 2003/0008000 (2003-01-01), Wong et al.
Lunn D.P. et al. Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene. Vaccine. May 4, 1999;17(18):2245-58.
Soboll, G. et al. Regional antibody and cellular immune responses to equine influenza virus infection, and particle mediated DNA vaccination.Vet Immunol Immunopathol. Jul. 15, 2003;94(1-2):47-62.
Nelson, K.M. et al. Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination. Vaccine. Aug. 1998;16(13):1306-13.
Soboll, G. et al. Mucosal co-administration of cholera toxin and influenza virus hemagglutinin-DNA in ponies generates a local IgA response. Vaccine. Jun. 20, 2003;21(21-22):3081-92.
Olsen, C.W. DNA vaccination against influenza viruses: a review with emphasis on equine and swine influenza. Vet Microbiol. May 22, 2000;74(1-2):149-64. Review.
Olsen, C.W. et al. Immunogenicity and efficacy of baculovirus-expressed and DNA-based equine influenza virus hemagglutinin vaccines in mice.Vaccine. Jul. 1997;15(10):1149-56.
Chen, Z. et al. Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs. Vaccine. Feb. 26, 1999;17(7-8):653-9.
Larsen, D.L. et al. Coadministration of DNA encoding interleukin-6 and hemagglutinin confers protection from influenza virus challenge in mice. J Virol. Feb. 1998;72(2):1704-8.
Invitrogen web page for pcDNA3. 1/V5-His TOPO expression kit; Accessed on Monday, Feb. 28, 2005 at + https://catalog.invitrogen.com/index.cfm?fuseaction=viewCatalog.viewProductDetails&sku=K480040&productDescription=686.
Kasof, G.M. et al. Btf, a novel death-promoting transcriptional repressor that interacts with Bcl-2-related proteins.Mol Cell Biol. Jun. 1999;19(6):4390-404.
STIC search of SEQ ID No. 1, Results 1, 5 of .rge.
STIC search of SEQ ID No. 1, Results 1 (2001), 5 (1996) or .rge (search done Mar. 1, 2005).
“Diverged Evolution of Recent Equine-2 Influenza (H3N8) Viruses in Western Hemisphere” by Lai et al., Dec. 14, 2000,Archives of Virology 146(2001) 1063-1074.
“Alternate Circulation of Recent Equine-2 Influenza Viruses (H3N8) From Two Distinct Lineages in the United States” by Lai et al.,Virus Research 100(2004) 159-164.
“WHO/OIE Meeting: Consulation on Newly Emerging Strains of Equine Influenza” by Mumford et al.,Vaccine, vol. 11, Issue 11 (1993) 1172-1175.
“Antigenicity and Immunogenicity of Experimental Equine Influenza ISCOM Vaccines” by Mumford et al.,Vaccine, vol. 21, Issue 9 (1994) 857-863.
“Protection Against a Lethal Influenza Virus Challenge by Immunization with a Haemagglutinin-Expressing Plasmid DNA” by Robinson et al.,Vaccine, vol. 11, Issue 9 (1993) 957-960.
“Protection of Ferrets Against Influenza Challenge with a DNA Vaccine to the Haemagglutinin” by Webster et al.,Vaccine, vol. 12, Issue 16 (1994) 1495-1498.
“Antibody Responses to DNA Vaccination of Horses Using the Influenza Virus Hemagglutinin Gene” by Lunn et al.,Vaccine, vol. 17 (1999) 2245-2258.
“DNA Vaccines: Protective Immunizations by Parenteral, Mucosal, and Gene-Gun Inoculations” by Fynan et al.,Proc. Natl. Acad. Sci. USAvol. 90 (1993) 11478-11482.
“Receptor Binding and Membrane Fusion in Virus Entry: The Influenza Hemagglutinin” by Skehel et al.,Annu. Rev. Biochem.vol. 69 (2000) 531-569.
“DNA Vaccination Against Respiratory Influenza Virus Infection” by Wong et al.,Vaccine, vol. 19 (2001) 2461-2467.
Board of Regents for Oklahoma State University
Campell Bruce R.
Fellers Snider Blankenship Bailey & Tippens, P.C.
Salvoza M. Franco
LandOfFree
DNA vaccine expressing HA1 of equine-2 influenza virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA vaccine expressing HA1 of equine-2 influenza virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA vaccine expressing HA1 of equine-2 influenza virus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3747763